Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Molecular basis of the effect of atorvastatin pretreatment on stem cell therapy in chronic ischemic diseases - critical limb ischemia

A. Adamičková, A. Gažová, M. Adamička, N. Chomaničová, S. Valašková, Z. Červenák, B. Šalingová, J. Kyselovič

. 2021 ; 70 (Suppl. 4) : S527-S533. [pub] 20211230

Language English Country Czech Republic

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22009505

Autologous stem cell therapy is the most promising alternative treatment in patients with chronic ischemic diseases, including ischemic heart disease and critical limb ischemia, which are characterized by poor prognosis related to serious impair of quality of life, high risk of cardiovascular events and mortality rates. However, one of the most serious shortcomings of stem cell transplantation are low survival after transplantation to the site of injury, as large number of stem cells are lost within 24 hours after delivery. Multiple studies suggest that combination of lipid-lowering drugs, statins, and stem cell transplantation might improve therapeutic efficacy in regenerative medicine. Statins are inhibitors of HMG-CoA reductase and belong to recommended therapy in all patients suffering from critical limb ischemia. Statins possess non-lipid effects which involve improvement of endothelial function, decrease of vascular inflammation and oxidative stress, anti-cancer and stem cell modulation capacities. These non-lipid effects are explained by inhibition of mevalonate synthesis via blocking isoprenoid intermediates synthesis, such as farnesylpyrophospate and geranylgeranylpyrophospate and result in modulation of the PI3K/Akt pathway. Moreover, statin-mediated microRNA regulation may contribute to the pleiotropic functions. MicroRNA interplay in gene regulatory network of IGF/Akt pathway may be of special significance for the treatment of critical limb ischemia. We assume further studies are needed for detailed analysis of statin interactions with microRNA at the molecular level and their link to PI3K/Akt and IGF/Akt pathway in stem cells, which are currently the most promising treatment strategy used in chronic ischemic diseases.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22009505
003      
CZ-PrNML
005      
20250617141846.0
007      
ta
008      
220419s2021 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934718 $2 doi
035    __
$a (PubMed)35199541
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Samáková, Adriana, $d 1993- $u 5th Department of Internal Medicine, Faculty of Medicine, Comenius University Bratislava, Slovakia $7 xx0267319
245    10
$a Molecular basis of the effect of atorvastatin pretreatment on stem cell therapy in chronic ischemic diseases - critical limb ischemia / $c A. Adamičková, A. Gažová, M. Adamička, N. Chomaničová, S. Valašková, Z. Červenák, B. Šalingová, J. Kyselovič
520    9_
$a Autologous stem cell therapy is the most promising alternative treatment in patients with chronic ischemic diseases, including ischemic heart disease and critical limb ischemia, which are characterized by poor prognosis related to serious impair of quality of life, high risk of cardiovascular events and mortality rates. However, one of the most serious shortcomings of stem cell transplantation are low survival after transplantation to the site of injury, as large number of stem cells are lost within 24 hours after delivery. Multiple studies suggest that combination of lipid-lowering drugs, statins, and stem cell transplantation might improve therapeutic efficacy in regenerative medicine. Statins are inhibitors of HMG-CoA reductase and belong to recommended therapy in all patients suffering from critical limb ischemia. Statins possess non-lipid effects which involve improvement of endothelial function, decrease of vascular inflammation and oxidative stress, anti-cancer and stem cell modulation capacities. These non-lipid effects are explained by inhibition of mevalonate synthesis via blocking isoprenoid intermediates synthesis, such as farnesylpyrophospate and geranylgeranylpyrophospate and result in modulation of the PI3K/Akt pathway. Moreover, statin-mediated microRNA regulation may contribute to the pleiotropic functions. MicroRNA interplay in gene regulatory network of IGF/Akt pathway may be of special significance for the treatment of critical limb ischemia. We assume further studies are needed for detailed analysis of statin interactions with microRNA at the molecular level and their link to PI3K/Akt and IGF/Akt pathway in stem cells, which are currently the most promising treatment strategy used in chronic ischemic diseases.
650    12
$a atorvastatin $x farmakologie $x terapeutické užití $7 D000069059
650    12
$a chronická kritická ischemie končetin $x farmakoterapie $x terapie $7 D000089802
650    12
$a končetiny $x krevní zásobení $7 D005121
650    _2
$a lidé $7 D006801
650    12
$a statiny $x farmakologie $x terapeutické užití $7 D019161
650    12
$a ischemie $x farmakoterapie $x terapie $7 D007511
650    12
$a fosfatidylinositol-3-kinasy $x metabolismus $7 D019869
650    _2
$a kvalita života $7 D011788
650    12
$a transplantace kmenových buněk $7 D033581
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gažová, Andrea, $d 1980- $7 xx0255822 $u Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University Bratislava, Slovakia
700    1_
$a Adamička, Matúš $7 xx0333142 $u Institute of Medical Biology, Genetics and Clinical Genetics, Faculty of Medicine, Comenius University Bratislava, Slovakia
700    1_
$a Sabová, Nikola, $d 1993- $7 xx0267320 $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University Bratislava, Slovakia
700    1_
$a Valášková, Simona, $d 1985- $7 xx0302182 $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University Bratislava, Slovakia
700    1_
$a Červenák, Zdenko $7 xx0333145 $u 5th Department of Internal Medicine, Faculty of Medicine, Comenius University Bratislava, Slovakia
700    1_
$a Šalingová, Barbara $7 xx0333146 $u 5th Department of Internal Medicine, Faculty of Medicine, Comenius University Bratislava, Slovakia
700    1_
$a Kyselovič, Ján, $d 1963- $7 xx0082943 $u 5th Department of Internal Medicine, Faculty of Medicine, Comenius University Bratislava, Slovakia
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 70, Suppl. 4 (2021), s. S527-S533
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35199541 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20220419 $b ABA008
991    __
$a 20250617141838 $b ABA008
999    __
$a ok $b bmc $g 1797013 $s 1160703
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 70 $c Suppl. 4 $d S527-S533 $e 20211230 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK124 $a Pubmed-20220419

Find record

Citation metrics

Archiving options